The announcement details the completion of a related transaction where Luoxin Pharmaceutical Group acquired a 19.0526% equity stake in its subsidiary, Beijing Health Technology, from Chengdu Deyixin. The total investment amounted to RMB 67.56052 million, increasing the company's ownership in Beijing Health from 80.9474% to 100%. The transaction aims to optimize governance and enhance operational efficiency.
Summary generated by AI · Always verify with source document
Luoxin Pharmaceutical Group Co., Ltd. (hereinafter referred to as "the Company") and all members of the Board of Directors guarantee that the content of this information disclosure is true, accurate, and complete, without false records, misleading statements, or significant omissions.
Sign in to read the full translation
Free accounts get 10 full releases per month. Pro subscribers get unlimited access.